🔎 Trials Near Me

Utama › Pendarahan › Georgia

Kajian klinikal Pendarahan di Georgia

7 kajian untuk Pendarahan sedang mencari peserta di lokasi di Georgia.

Bandar di Georgia

Teks kajian rasmi (Bahasa Inggeris)

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  • Atlanta Clinical Research Centers, Atlanta
  • NSC Research, Inc, Johns Creek
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07626411

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  • Grady Health System, Atlanta
  • NSC Research, Inc, Johns Creek
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07175428

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Emory University, Atlanta
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Emory University, Atlanta
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06948318

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  • Emory University, Atlanta
  • Piedmont Healthcare Inc., Atlanta
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Jun 2026 · NCT04045665

Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures

  • University Surgical Vascular, Watkinsville
Mengambil peserta
Umur 18 hingga 75 · Semua jantina · Dikemas kini 8 Mei 2026 · NCT06647017

Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)

  • Arthur M. Blank Hospital | Children's Healthcare of Atlanta, Atlanta
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 1 Dis 2025 · NCT07136857

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.